Clinical Trial Update: Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on clazakizumab for highly HLA-sensitized patients awaiting kidney transplant; the study spans Phase 1/2 with status ACTIVE_NOT_RECRUITING…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody-mediated Rejection
• Chronic Kidney Disease
• End-stage Renal Disease
• Kidney Transplant Complications
• Kidney Transplant Failure
• Kidney Transplant Rejection
• Transplant Glomerulopathy

Drugs mentioned

• Clazakizumab (clazakizumab)

Snippet

Sponsor: Stanley Jordan, MD | Conditions: Kidney Failure, Chronic, End-Stage Renal Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING